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Understanding the roles of genes and proteins and the
functional consequences of their mutation is mandatory
for the interpretation of a resulting phenotype, for exam-
ple the observed disease state. Biomedical scientists are
approaching this task from different angles. Typically
individual research projects investigate the consequences
of natural and experimental mutations in proteins by ana-
lysing stability and the resulting changes to a protein's
function [1]. The consequences of such changes may be
used in simulations and subsequent population studies
may analyse cohorts for genetic variability, after which
review of the observed phenotypes in each of the cohort's
individuals may occur [2,3]. Results are reported in the
scientific literature and in biomedical databases but are
not necessarily integrated according to a detailed and
comprehensive knowledge representation, nor are they
accessible for reuse by multiple stakeholders.
Annotation of mutations with their relevance for pheno-
typic expression is crucial to the understanding of genetic
mechanisms, biological processes and complex diseases.
Large-scale resources able to cope with the full extent of
data and annotations reporting on human variability (see
1000 genomes project) have yet to be built [4]. Systems
maintaining this data will have to deal with a number of
problems: (i) extraction, storage and reuse of genotype-
phenotype information [5,6], (ii) preparation of semantic 
resources for phenotype description (phenotype ontolo-
gies, e.g. human phenotype ontology) [7,23], and (iii)
automated interpretation, simulation and prediction of
functional changes induced by mutations and sequence
variants [8].
In principle, a complete solution that allows efficient
hypothesis generation based on annotated mutation
information would be able to derive, from the location of
the mutation, changes in protein structure and function
thus allowing prediction of changes in the protein's activ-
ity and the molecular processes that are affected. Finally,
it would realize and describe the overall changes in the
microscopic, physiological and macroscopic phenotype.
Such a solution is not yet in sight.
The integration of data from different experimental and
simulation methods as well as the annotation of data with
rich semantic resources (bio-ontologies [9]) are the most
important next steps [10]. To date, moving from SNP to
sequence to structure and function has been addressed
with varying degrees of accuracy with sequence and struc-
ture based methods. The need to apply prediction tech-
niques at a genomic scale requires that adequate solutions
have to be identified and benchmarked against reliable
measures. Only then can we anticipate and design solu-
tions to address changes expected from significant muta-
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tions. In this context the reuse of existing mutations and
annotations, from databases and those mined from the
literature, for checking the quality of predictions is piv-
otal.
In order to assess the state of the art in the annotation,
interpretation, management of mutations several initia-
tives and events have recently taken place [11,12]
These events have brought to light the challenges, the
existing solutions and relevant expertise within the
research community. This supplement to BMC Bioinfor-
matics  on mutation related IT solutions gives further
insight on the current state of research in this important
domain. The presented research is mainly concerned with
the impact of mutations on protein stability and protein
function but also includes reports on attempts to predict
the relevance of a protein's modifications in the context of
the disease under investigation. Several publications
report on the annotation of mutations in the correspond-
ing gene/protein with information extracted from the sci-
entific literature. A number of the studies used specific
protein families to demonstrate the usefulness of the find-
ings.
It is clearly an ambitious goal to discover novel knowledge
from the literature by contrasting the retrieved content
against reference data resources [13]. For the protein
kinases, [14] processed a large set of documents to iden-
tify mutations and validate the results against against Kin-
MutBase, revealing an overlap of only 52%. In other
approaches, contextual information in neighbouring text
was used to find functional annotations of protein resi-
dues that could be evaluated against UniProtKb [15] or to
efficiently retrieve documents reporting on mutations that
destabilise G protein-coupled receptors [16]. In the latter
case, the reported destabilisation effects were evaluated
against sequence based predictors. Contextual informa-
tion in Medline abstracts was also exploited, using differ-
ent machine learning based classifiers, to predict the
stability and the disease relevance of mutations in lipase
and amylase enzymes [17].
Two further publications describe the integration of
extracted mutations into solutions that support interpre-
tation of SNPs in a larger context. Mutations can be visu-
alized in a 3D representation of the protein's structure to
better understand the induced effects of the mutation
through its three-dimensional localisation [18]. In
another approach, the impact of changes to a protein's
activity due to its mutation can be traced through protein
network simulation [2]. The authors use the example of
MEK1 activation of Akt to demonstrate the usefulness of
this approach. Both publications show the complexity of
the integration tasks, reveal new methodologies – based
in part on existing infrastructure, and illustrate new bio-
logical insights in the context of existing biological mod-
els.
In parallel, other researchers seek to predict the conse-
quence of sequence variation on biological processes.
One research team has focused on mutations in mito-
chondrial sequences and their relevance for diseases. They
propose and evaluate a scoring function that has been
tested against other prediction methods (SIFT, PolyPhen,
PHD-SNP, PLHOST) [19]. In another study, changes in a
protein sequence and the protein's stability were assessed
in the context of changes in the protein's function – which
is assumed to be crucial to the development of a disease
state [1]. These researchers showed that changes to the
protein's stability have an effect on the protein's function,
but there are also cases where the function is not altered at
all. In a similar approach, another team used features
from protein annotations (e.g., from UniProt) to classify
mutations so as to predict changes in the protein's func-
tion and its relevance for diseases [20]. Clearly, taken in
isolation the criterion of large scale change in a protein's
stability is not sufficient to distinguish deleterious muta-
tions and neutral variation. Finally, [21] analyse the adap-
tations of the HIV virus during the drug treatment of the
patients. The genetic variability in the virus' protease is
evaluated under the evolutionary pressure induced by the
treatment of the patients with a varying number of anti-
viral drugs.
Altogether, this special issue gives an overview on the
scope of ongoing research to exploit resources reporting
on genetic variability. The full integration of all such
resources is work in progress and clearly a necessary
research direction with significant impact on many areas
of biomedical science. Through a renewed community
focus on life science infrastructure [9,22] there are oppor-
tunities to define a roadmap for technology development
in this domain and to evolve existing approaches into a
robust framework for phenotype prediction, based on
annotations and interpretation of mutation data. Clearly
many stakeholders and skills sets are required and a
strong community focus must be present.
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